Simpson Thacher is representing Warburg Pincus in connection with a $76.5 million Series C funding round for Outset Medical.
A new investor, funds advised by T. Rowe Price Associates, Inc., led the round, with participation from existing investors including Warburg Pincus.
Outset is a pioneering medical technology company focused on transforming the patient’s care experience as well as finding cost-effective solutions for both patients and providers.
The Simpson Thacher team included Robert Langdon and Mark Myott (M&A); and David Rubinsky and Jeannine McSweeney (ECEB).
Involved fees earner: Robert Langdon – Simpson Thacher & Bartlett; Mark Myott – Simpson Thacher & Bartlett; David Rubinsky – Simpson Thacher & Bartlett; Jeannine McSweeney – Simpson Thacher & Bartlett;
Law Firms: Simpson Thacher & Bartlett;
Clients: Warburg Pincus;